
Blog
Cancer Biomarkers Market Accelerates on Precision Oncology Momentum, Set to Cross USD 72.64 Billion by 2032
Market Overview: Precision Diagnostics Reshape Oncology Care The cancer biomarkers market is entering a high-growth phase as healthcare systems increasingly prioritize early detection, targeted therapy,
